Related Experiment Video
Updated: May 1, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Obesity as assessed by body adiposity index and multivariable cardiovascular disease risk
Satvinder S Dhaliwal1, Timothy A Welborn2, Louise G H Goh1
1Curtin University, Perth, Australia.
Insights
Body Adiposity Index (BAI) did not effectively predict cardiovascular disease (CVD) or coronary heart disease (CHD) mortality in Australian men. Waist circumference (WC) and waist-hip ratio (WHR) were significant predictors, unlike BAI and body mass index (BMI).
Area of Science:
- Cardiology
- Public Health
- Obesity Research
Background:
- Cardiovascular disease (CVD) and coronary heart disease (CHD) remain leading causes of mortality worldwide.
- Accurate prediction of CVD and CHD risk is crucial for effective prevention strategies.
- Various anthropometric measures are used to assess obesity, but their comparative predictive values for mortality differ.
Purpose of the Study:
- To evaluate the Body Adiposity Index (BAI) in predicting CVD and CHD mortality.
- To compare the predictive performance of BAI against Body Mass Index (BMI), Waist Circumference (WC), and Waist-to-Hip Ratio (WHR).
- To determine the effectiveness of these obesity measures after adjusting for established risk factors.
Main Methods:
- A prospective 15-year mortality follow-up study of 4175 Australian males.
- Exclusion criteria included pre-existing heart disease, diabetes, and stroke.
- Multivariable logistic regression was employed to analyze the association between obesity measures and CVD/CHD mortality, with and without adjustment for Framingham Risk Scores (FRS).
Main Results:
- The predictive ability of BAI for CVD and CHD mortality was not significant after adjustment for age and FRS.
- BMI also showed limited predictive significance after adjustments.
- Both WC and WHR were significant predictors of CVD and CHD mortality, maintaining significance after covariate adjustment.
Conclusions:
- While BAI may reflect body fat percentage, it proved ineffective in predicting CVD and CHD mortality in this cohort.
- WC and WHR emerged as superior and robust predictors of cardiovascular and coronary heart disease mortality compared to BAI and BMI.
- These findings highlight the importance of central adiposity measures for cardiovascular risk assessment.
Abstract:
To assess the role of body adiposity index (BAI) in predicting cardiovascular disease (CVD) and coronary heart disease (CHD) mortality, in comparison with body mass index (BMI), waist circumference (WC), and the waist circumference to hip circumference ratio (WHR). This study was a prospective 15 year mortality follow-up of 4175 Australian males, free of heart disease, diabetes and stroke. The Framingham Risk Scores (FRS) for CHD and CVD death were calculated at baseline for all subjects. Multivariable logistic regression was used to assess the effects of the measures of obesity on CVD and CHD mortality, before adjustment and after adjustment for FRS. The predictive ability of BAI, though present in the unadjusted analyses, was generally not significant after adjustment for age and FRS for both CVD and CHD mortality. BMI behaved similarly to BAI in that its predictive ability was generally not significant after adjustments. Both WC and WHR were significant predictors of CVD and CHD mortality and remained significant after adjustment for covariates. BAI appeared to be of potential interest as a measure of % body fat and of obesity, but was ineffective in predicting CVD and CHD.
Related Concept Videos
Obesity
Coronary Artery Disease I: Introduction
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Coronary Artery Disease IV: Preventive Measures

